WallStreetZenWallStreetZen

NYSEMKT: ELMD
Electromed Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Electromed earnings were $6.8M for the trailing 12 months ending Dec 31, 2024, with 66% growth year over year. The latest ELMD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $2.0M, up 33.5% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, ELMD reported annual earnings of $5.2M, with 62.7% growth. The next ELMD earnings date is May 5, 2025.

ELMD past earnings growth

How has ELMD's earnings growth performed historically?

Company
65.96%
Industry
48.48%
Market
65.38%
ELMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ELMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ELMD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ELMD earnings history

Current Revenue
$59.6M
Current Earnings
$6.8M
Current Profit Margin
11.3%
ELMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ELMD Return on Equity

Current Company
15.7%
Current Industry
11.5%
Current Market
34.1%
ELMD's Return on Equity (15.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ELMD undefined

Current Company
13.4%
Current Industry
8%
ELMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELMD announces earnings.

ELMD undefined

Current Company
21.29%
Current Industry
9%
ELMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELMD$10.09M$6.76M+12.65%$0.78
LUNG-$49.05M-$56.39MN/A-$1.44
MASS-$67.81M-$72.21MN/A-$2.12
CVRX-$54.89M-$59.97MN/A-$2.65
INGN-$15.47M-$35.89MN/A-$1.52
View Top Medical Device Stocks

ELMD earnings dates

Next earnings date
May 5, 2025

Electromed Earnings Reports & History FAQ

What were Electromed's earnings last quarter?

On ELMD's earnings call on Invalid Date, Electromed (NYSEMKT: ELMD) reported Q4 2024 earnings per share (EPS) of $0.23, up 15% year over year. Total ELMD earnings for the quarter were $1.97 million. In the same quarter last year, Electromed's earnings per share (EPS) was $0.20.

If you're new to stock investing, here's how to buy Electromed stock.

When does Electromed report earnings?

The next ELMD earnings date is Invalid Date. Add ELMD to your watchlist to be reminded of Electromed's next earnings date.

Is Electromed profitable or losing money?

As of the last Electromed earnings report, Electromed is currently profitable. Electromed's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $6.76 million, a 71.78% increase year over year.

What was ELMD's earnings growth in the past year?

As of Electromed's earnings date in Invalid Date, Electromed's earnings has grown 65.96% year over year. This is 17.48 percentage points higher than the US Medical Devices industry earnings growth rate of 48.48%. ELMD earnings in the past year totalled $6.76 million.

What are Electromed's earnings expectations?

The current EPS estimate for Electromed's earnings report in Invalid Date is $0.21.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.